InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NMN | price predictions? | 29/12/11 | 1 | 583 | |||
|
|||||||
NMN | Ann: Change of Company Name | 07/10/10 | 1 | 442 | |||
|
|||||||
NMN | Ann: Results of Meeting | 06/10/10 | 2 | 501 | |||
|
|||||||
NMN | Ann: New Company Constitution | 06/10/10 | 0 | 216 | |||
|
|||||||
NMN | Ann: Company Presentation | 01/10/10 | 3 | 574 | |||
|
|||||||
NMN | Ann: Full Year Statutory Accounts | 29/09/10 | 0 | 241 | |||
|
|||||||
NMN | Ann: Appointment of Company Secretary | 28/09/10 | 0 | 209 | |||
|
|||||||
NMN | Ann: Surface Sampling Results Identifies Further | 23/09/10 | 2 | 397 | |||
|
See All Discussions